CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,724,648
- in 7 filings, $2.7M under 10b5-1 plans
Net −$2,724,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-19 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −500 | $15.00 | $8K | 6,781 |
| 2024-08-19 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −500 | 10,879 | ||
| 2024-07-16 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +500 | $6.49 | $3K | 7,281 |
| 2024-07-16 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,250 | $8.04 | $10K | 8,531 |
| 2024-07-16 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,750 | $27.11 | $47K | 6,781 |
| 2024-07-16 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −500 | 11,379 | ||
| 2024-07-16 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,250 | 32,502 | ||
| 2024-07-11 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,996 | $15.78 | $31K | 8,777 |
| 2024-07-11 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,996 | $25.00 | $50K | 6,781 |
| 2024-07-11 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,996 | 23,004 | ||
| 2024-07-10 | Kirn David Chief Executive Officer | Option exercise 10b5-1 | +11,653 | $14.42 | $168K | 1,070,806 |
| 2024-07-10 | Kirn David Chief Executive Officer | Option exercise 10b5-1 | +1,270 | $15.78 | $20K | 1,072,076 |
| 2024-07-10 | Kirn David Chief Executive Officer | Sale 10b5-1 | −12,923 | $22.49 | $291K | 1,059,153 |
| 2024-07-10 | Kirn David Chief Executive Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −11,653 | 565,417 | ||
| 2024-07-10 | Kirn David Chief Executive Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,270 | 148,730 | ||
| 2024-07-01 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,332 | $6.49 | $9K | 3,069 |
| 2024-07-01 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +2,916 | $8.04 | $23K | 5,985 |
| 2024-07-01 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −4,248 | $21.36 | $91K | 1,737 |
| 2024-07-01 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,332 | 11,879 | ||
| 2024-07-01 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −2,916 | 33,752 |
Page 6 of 16 · 319 trades